Aerolized prostacyclin for preoperative evaluation and postoperative treatment of patients with pulmonary hypertension;Aerosolisiertes Prostazyklin zur praoperativen Evaluation und postkardiochirurgischen Behandlung von Patienten mit pulmonaler Hypertension

Zeitschrift fur Kardiologie

Volumn 86, Issue 2, 1997, Pages 71-80

  Schulze Neick, I ^a   Uhlemann, F ^a   Nurnberg J H ^a   Bultmann M ^a   Haas, N A ^a   Dahnert I ^a   Alexi Meshkishvili, V ^a   Opitz, C ^c   Pappert, D ^b   Rossaint, R ^b   Kleber, F X ^c   Hetzer, R ^a   Lange, P E ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

aerosol; evaluation; postoperative; prostacyclin; pulmonary hypertension

Indexed keywords

NITRIC OXIDE; PROSTACYCLIN; VASODILATOR AGENT;

ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EISENMENGER COMPLEX; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; POSTOPERATIVE PERIOD; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; ADOLESCENT; AEROSOL; CONGENITAL HEART MALFORMATION; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART SEPTUM DEFECT; HEART STROKE VOLUME; INFANT; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE; LUNG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATION; PREMEDICATION; PRESCHOOL CHILD; VASCULARIZATION;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AEROSOLS; CHILD; CHILD, PRESCHOOL; CRITICAL CARE; EISENMENGER COMPLEX; EPOPROSTENOL; FEMALE; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HEART SEPTAL DEFECTS; HUMANS; HYPERTENSION, PULMONARY; INFANT; LUNG; MALE; MIDDLE AGED; NITRIC OXIDE; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; STROKE VOLUME; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 0030611394     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920050036     Document Type: Article

References (27)

1. Rossaint R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 238:399-405
2. Kinsella JP, Neish SR, Shaffer E, Abman SH (1992) Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet 340 (Oct 3): 819-820
3. Müller W, Kachel W, Lasch P, Varnholt V, König S (1996) Inhaled nitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn. Int Care Med 22:71-76
4. Schulze-Neick I, Uhlemann F, Bültmann M, et al. (1995) Inhaled Nitric Oxide in Postoperative Congenital Heart Disease: Special Considerations. Intens Care Med 21 (Suppl 1):S37
5. Kieler-Jensen N, Ricksten S, Stenqvist O, et al. (1994) Inhaled nitric oxide in the evaluation of heart transplantation candidates with elevated pulmonary vascular resistance. J Heart Lung Transplant 13:366-75
6. Journois D, Pouard P, Mauriat P, Malhere T, Vouhe P, Safran D (1994) Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg 107(4): 1129-35
7. Roberts JDJ, Lang P, Bigatello LM, Vlahakes GJ, Zapol WM (1993) Inhaled nitric oxyde in congenital heart disease. Circulation 87:447-153
8. Miller O, Celermajer D, Deanfield J, Macrae D (1994) Guidelines for the safe administration of inhaled nitric oxide. Arch Dis Child 70:47-49
9. Wessel D, Adatia I, Thompson J, Hickey P (1994) Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension. Crit Care Med 22:930-8
10. Ivy DD, Wiggings JW, Badesch DB, Kinsella JP, Kelminson LL, Abman SH (1994) Nitric oxide and prostacyclin treatment of an infant with primary pulmonary hypertension. Am J Cardiol 74:414-416
11. Bush A, Busst C, Knight WB, Shinebourne EA (1988) Comparison of the haemodynamic effects of epoprostenol (prostacyclin) and tolazolin. Br Heart J 60:141-8
12. Hausdorf G, Morf G, Berdjis F, et al (1992) Postoperative pulmonale Hypertension: Therapie bei Kindern mit angeborenen Herzfehlern. Z Herz Th Gefäßchir 6: 318-22
13. Schranz D, Kuroczynski W, Jacob H, et al (1992) Behandlung der pulmonalen Hypertension nach Korrektur angeborener Herzfehler: Stellenwert von Prostacyclin. Z Herz Th Gefäßchir 6:311-7
14. Vane JR (1982) Prostacyclin: A prostaglandin with therapeutic potential. Arch Pharmacol Toxicol 8:51-76
15. Olschewski H, Walmrath D, Schermuly R, Ghofrany A, Grimminger F, Seeger W (1996) Aerosolized Prostacyclin and Iloprost in Severe Pulmonary Hypertension. Ann Intern Med 124:in press
16. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342 (Oct 16):961-962
17. Bein T, Pfeifer M, Riegger W, Taeger K (1994) Continuous Intraarterial Measurement of Oxygenation during Aerosolized Prostacyclin-Administration in Severe Respiratory Failure. NEJM 331 (5):335-6
18. Habler E, Kleen M, Takenaka S, et al. (1995) Eight hour's inhalation of prostacyclin aerosol in healthy lambs causes no signs of respiratory-tract tissue damage. Intensive Care Med 21 (Suppl I):S52
19. Lock JE, Keane JF, Mandell VS, Perry SB (1992) Cardiac Catheterization. In: Fyler DL (ed) Nadas' Pediatric Cardiology. Hanley & Belfus, Philadelphia, pp 187-223
20. Schulze-Neick I, Bültmann M, Werner H, et al (1996) Quantitative Echokardiographie des rechten Ventrikels zur Beurteilung der Therapie mit inhalativem Stickmonoxyd bei der postoperativen Betreuung von Patienten mit angeborenen Herzfehlern. Herz Thorax Gefäßchir 10 (2):1-6
21. Frostell C, Fratacci M-D, Wain JC, Jones R, Zapol WM (1991) Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation 83:2038-2047
22. Scherrer U, Vollenweider L, Delabays A (1996) Inhaled nitric oxide for high altitude pulmonary edema. N Engl J Med 334: 624-9
23. Walmrath D, Schneider T, Schermuly R, Olschewski H, Grimminger F, Seeger W (1996) Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. Am J Respir Crit Care Med 153:in press
24. 2) in aqueous solutions. Prostaglandins 15 (6):943-954
25. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res 25:329-340
26. Santak B, Schreiber M, Kühn P, Lang D, Radermacher P (1995) Prostacyclin aerosol in an infant with pulmonary hypertension. Eur J Ped: in press
27. Ichinose F, Adrie C, Hurford W, Zapol W (1995) Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J Appl Physiol 78 (4): 1288-95